Pharmacyte Biotech Inc (OTCMKTS:PMCB) is about to start Phase 2b human clinical trial in pancreatic cancer in some time. Before the trial begins, the company…
Pharmacyte Biotech Inc (OTCMKTS:PMCB) released an educational article that will allow people to know about its technology and its application in pancreatic…
Pharmacyte Biotech Inc (OTCMKTS:PMCB) has decided to discuss some of its major milestones right before the phase 2b clinical trial in pancreatic cancer…
Pharmacyte Biotech Inc (OTCMKTS:PMCB) may not be as large as many other biotech firms around the world, but the innovative technologies used by it are…
Pharmacyte Biotech Inc (OTCMKTS:PMCB) revealed that it finalized a contract with Imaging Endpoints in Arizona for completion of radiologic imaging process…
Leading biotech company Pharmacyte Biotech Inc (OTCMKTS:PMCB) is known for using high-end technologies to develop drugs for cancer and other diseases….
Pharmacyte Biotech Inc (OTCMKTS:PMCB) stated that its CEO, Mr. Kenneth L. Waggoner, JD expressed his views on the company’s development plans and talked…
Pharmacyte Biotech Inc (OTCMKTS:PMCB) biotech entity in clinical stage working to advance targeted treatments for patients suffering from diabetes and…
Pharmacyte Biotech Inc (OTCMKTS:PMCB) reported that Chardan Capital Markets LLC, a global investment bank specializing in small, mid-cap and micro firms,…
So far in this year, there are some OTC listed biotech firms that have managed to fetch investors’ attention. One of such company is Pharmacyte Biotech…
